The IDSA Center for Global Health Policy and the HIV Medicine Association released a policy statement on the results of HPTN 052 with recommendations for U.S. global and domestic AIDS Policy. Entitled “U.S. Policy and Funding on AIDS Should Follow the Science,” the statement recommends that a larger share of the PEPFAR budget be devoted […]
The following is a blog post by Kristen Jill Kresge of the International AIDS Vaccine Initiative. Writing from the AIDS Vaccine Conference in Bangkok, Thailand, Kresge provides a synopsis of the first plenary session of the conference. The post was originally published on IAVIReport. At the first plenary session of AIDS Vaccine 2011, which opened this […]
The following is a blog post by Jose Esparza, Deputy Director of HIV Vaccines at the Bill and Melinda Gates Foundation. Writing from the AIDS Vaccine Conference in Bangkok, Thailand, Dr. Esparza discusses recent scientific developments in the creation of an AIDS vaccine, and what we can expect to see in the future. The post […]
HIV
Amid unprecedented challenges to routine healthcare access, trial results mark a first for a critically needed HIV prevention measure An investigational drug administered by injection every […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
What we have learned from HIV can guide responses to COVID-19 that are innovative, effective and inclusive, and can help end the pandemic faster The following […]
Policy
The following is a guest post by Kenneth G. Castro, MD, FIDSA Since its formation in 1948, WHO has relied heavily on the U.S. for collaborations […]